Cargando…
Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. Th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024915/ https://www.ncbi.nlm.nih.gov/pubmed/35456568 http://dx.doi.org/10.3390/pharmaceutics14040734 |
_version_ | 1784690731109056512 |
---|---|
author | Zhang, Tingting Yang, Yushan Huang, Li Liu, Ying Chong, Gaowei Yin, Weimin Dong, Haiqing Li, Yan Li, Yongyong |
author_facet | Zhang, Tingting Yang, Yushan Huang, Li Liu, Ying Chong, Gaowei Yin, Weimin Dong, Haiqing Li, Yan Li, Yongyong |
author_sort | Zhang, Tingting |
collection | PubMed |
description | In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. These strategies either utilize biomimetic materials, as building blocks to construct inanimate entities whose functions are similar to natural living cells, or engineer immune cells with functional materials, to potentiate their anti-tumor effects. In this review, we will summarize these advanced strategies in different cell types, as well as discussing the prospects of this field. |
format | Online Article Text |
id | pubmed-9024915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90249152022-04-23 Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy Zhang, Tingting Yang, Yushan Huang, Li Liu, Ying Chong, Gaowei Yin, Weimin Dong, Haiqing Li, Yan Li, Yongyong Pharmaceutics Review In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. These strategies either utilize biomimetic materials, as building blocks to construct inanimate entities whose functions are similar to natural living cells, or engineer immune cells with functional materials, to potentiate their anti-tumor effects. In this review, we will summarize these advanced strategies in different cell types, as well as discussing the prospects of this field. MDPI 2022-03-29 /pmc/articles/PMC9024915/ /pubmed/35456568 http://dx.doi.org/10.3390/pharmaceutics14040734 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Zhang, Tingting Yang, Yushan Huang, Li Liu, Ying Chong, Gaowei Yin, Weimin Dong, Haiqing Li, Yan Li, Yongyong Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy |
title | Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy |
title_full | Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy |
title_fullStr | Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy |
title_full_unstemmed | Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy |
title_short | Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy |
title_sort | biomimetic and materials-potentiated cell engineering for cancer immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024915/ https://www.ncbi.nlm.nih.gov/pubmed/35456568 http://dx.doi.org/10.3390/pharmaceutics14040734 |
work_keys_str_mv | AT zhangtingting biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT yangyushan biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT huangli biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT liuying biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT chonggaowei biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT yinweimin biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT donghaiqing biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT liyan biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy AT liyongyong biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy |